Literature DB >> 27262061

Pitfalls and optimal approaches to diagnose melioidosis.

Paul Vijay Kingsley1, Govindakarnavar Arunkumar2, Meghan Tipre3, Mark Leader3, Nalini Sathiakumar3.   

Abstract

Melioidosis is a severe and fatal infectious disease in the tropics and subtropics. It presents as a febrile illness with protean manifestation ranging from chronic localized infection to acute fulminant septicemia with dissemination of infection to multiple organs characterized by abscesses. Pneumonia is the most common clinical presentation. Because of the wide range of clinical presentations, physicians may often misdiagnose and mistreat the disease for tuberculosis, pneumonia or other pyogenic infections. The purpose of this paper is to present common pitfalls in diagnosis and provide optimal approaches to enable early diagnosis and prompt treatment of melioidosis. Melioidosis may occur beyond the boundaries of endemic areas. There is no pathognomonic feature specific to a diagnosis of melioidosis. In endemic areas, physicians need to expand the diagnostic work-up to include melioidosis when confronted with clinical scenarios of pyrexia of unknown origin, progressive pneumonia or sepsis. Radiological imaging is an integral part of the diagnostic workup. Knowledge of the modes of transmission and risk factors will add support in clinically suspected cases to initiate therapy. In situations of clinically highly probable or possible cases where laboratory bacteriological confirmation is not possible, applying evidence-based criteria and empirical treatment with antimicrobials is recommended. It is of prime importance that patients undergo the full course of antimicrobial therapy to avoid relapse and recurrence. Early diagnosis and appropriate management is crucial in reducing serious complications leading to high mortality, and in preventing recurrences of the disease. Thus, there is a crucial need for promoting awareness among physicians at all levels and for improved diagnostic microbiology services. Further, the need for making the disease notifiable and/or initiating melioidosis registries in endemic countries appears to be compelling.
Copyright © 2016 Hainan Medical College. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Approaches route of infection; Diagnosis; Melioidosis pseudomallei; Pitfalls; Review; Treatment

Year:  2016        PMID: 27262061     DOI: 10.1016/j.apjtm.2016.04.003

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  10 in total

1.  A recombinase polymerase amplification lateral flow assay for rapid detection of Burkholderia pseudomallei, the causative agent of melioidosis.

Authors:  Apoorva Saxena; Vijai Pal; Nagesh Kumar Tripathi; Ajay Kumar Goel
Journal:  Braz J Microbiol       Date:  2022-01-10       Impact factor: 2.476

2.  Safer In Vitro Drug Screening Models for Melioidosis Therapy Development.

Authors:  Anna S Amiss; Jessica R Webb; Mark Mayo; Bart J Currie; David J Craik; Sónia Troeira Henriques; Nicole Lawrence
Journal:  Am J Trop Med Hyg       Date:  2020-11       Impact factor: 2.345

Review 3.  Melioidosis in Malaysia: A Review of Case Reports.

Authors:  Paul Vijay Kingsley; Mark Leader; Nandika Suranjith Nagodawithana; Meghan Tipre; Nalini Sathiakumar
Journal:  PLoS Negl Trop Dis       Date:  2016-12-22

4.  Comparison of Mast Burkholderia Cepacia, Ashdown + Gentamicin, and Burkholderia Pseudomallei Selective Agar for the Selective Growth of Burkholderia Spp.

Authors:  Carola Edler; Henri Derschum; Mirko Köhler; Heinrich Neubauer; Hagen Frickmann; Ralf Matthias Hagen
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2017-01-09

5.  Clinical, Bacteriologic, and Geographic Stratification of Melioidosis Emerges from the Sri Lankan National Surveillance Program.

Authors:  Harindra D Sathkumara; Adam J Merritt; Enoka M Corea; Shivankari Krishnananthasivam; Mohan Natesan; Timothy J J Inglis; Aruna Dharshan De Silva
Journal:  Am J Trop Med Hyg       Date:  2018-01-04       Impact factor: 2.345

6.  Diagnostic accuracy of the InBiOS AMD rapid diagnostic test for the detection of Burkholderia pseudomallei antigen in grown blood culture broth.

Authors:  Marjan Peeters; Panha Chung; Hua Lin; Kristien Mortelmans; Chhundy Phe; Chentha San; Laura Maria Francisca Kuijpers; Syna Teav; Thong Phe; Jan Jacobs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-03-28       Impact factor: 3.267

7.  Geographic Distribution and Incidence of Melioidosis, Panama1.

Authors:  Ana B Araúz; Katiana Castillo; Erika Santiago; Yarineth Quintero; Enrique Adames; Boris Castillo; Amalia Rodríguez-French; German Henostroza
Journal:  Emerg Infect Dis       Date:  2020-01       Impact factor: 6.883

8.  Unusual Presentations of Abdominal Melioidosis.

Authors:  Vignesh Kumar Mohan; Komalavalli Rajesh; Sripriya Srinivas; R Ravi; Jimmy Prabhakaran; K Srinivasan; Subha Sundaramoorthy
Journal:  J Glob Infect Dis       Date:  2021-01-29

9.  Rapid identification of melioidosis agent by an insulated isothermal PCR on a field-deployable device.

Authors:  Kek Heng Chua; E Wei Tan; Hwa Chia Chai; S D Puthucheary; Ping Chin Lee; Suat Moi Puah
Journal:  PeerJ       Date:  2020-05-27       Impact factor: 2.984

Review 10.  Melioidosis in Malaysia: Incidence, Clinical Challenges, and Advances in Understanding Pathogenesis.

Authors:  Sheila Nathan; Sylvia Chieng; Paul Vijay Kingsley; Anand Mohan; Yuwana Podin; Mong-How Ooi; Vanitha Mariappan; Kumutha Malar Vellasamy; Jamuna Vadivelu; Sylvia Daim; Soon-Hin How
Journal:  Trop Med Infect Dis       Date:  2018-02-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.